EGFR and nasopharyngeal carcinoma: The results indicated a statistically significant difference, and EGFR overexpression was associated with worse DFS in patients with nasopharyngeal carcinoma (HR = 2.53, 95% CI [1.84, 3.47], P < .01, Fig. 4).